| Original language | English |
|---|---|
| Article number | 256P |
| Journal | pA2 online |
| Volume | 13 |
| Issue number | 3 |
| Publication status | Published - 2015 |
ELISA screen of novel compounds that inhibit S100P and RAGE binding to identify new candidate drugs as a new therapy for pancreatic cancer.
Deborah Ogbeni, Ramatoulie Camara, David Chau, Stewart Kirton, Pryank Patel, Louise MacKenzie, Sharon Rossiter
- School of Life and Medical Sciences
- Agriculture, Food and Veterinary Sciences
- Basic and Clinical Science Unit
- Centre for Health Services and Clinical Research
- Centre for Research into Topical Drug Delivery and Toxicology
- Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Unit
- Biosciences Research Group
- Centre for Research in Mechanisms of Disease and Drug Discovery
- Department of Clinical, Pharmaceutical and Biological Science
- Centre for Future Societies Research
Research output: Contribution to journal › Meeting abstract › peer-review